Biotech news
Americas
In a global league, Canada’s biotech industry would be respectably mid table. LSIPR talks to Andrew Casey, president of industry association BIOTECanada, about how the organisation is trying to take it to the next level. 3 February 2014
Americas
The US Supreme Court has ruled that when licensees seek a declaratory judgement of non-infringement, the patentee bears the burden of proof to show infringement. 22 January 2014
Biotech
UK law firm Potter Clarkson LLP has made changes to its team with the appointment of two senior managers. 15 January 2014
Americas
IP law firm Sterne Kessler Goldstein & Fox PLLC has announced the election of three new directors to its life sciences team. 14 January 2014
Americas
General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion. 13 January 2014
Americas
Stem cells are seen by many as the great hope for medical research in the years to come. LSIPR spoke to Nicholas Seay, chief technology officer at Cellular Dynamics, about the importance of IP in this field. 13 January 2014
Americas
Enzo Biochem, a US biotechnology company, has received another $12.4 million from a patent ruling against Applera Corp, bringing the total damages sum to around $61 million. 7 January 2014
Americas
IP litigator Thomas Wintner has been appointed partner at Edwards Wildman Palmer LLP. 6 January 2014
Asia-Pacific
The High Court in Australia has said for the first time that a method of medical treatment for the human body can be a patentable invention. 12 December 2013
Biotech
Europe’s main life sciences laboratory has made a database containing details of around 15 million patented chemical structures available to the public for the first time. 11 December 2013